![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
DrStockPick.com Stock Report! 9/15/09, LXRX, ALNY, EBAY, EMAN, IM, GELV
Dr. Stock Pick (September 15th, 2009) Writes:
DrStockPick.com Stock Report!
Tuesday September 15, 2009
**************************************************************
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2 (SGLT2). LX4211 is Lexicon’s fourth drug candidate currently being tested in Phase 2 clinical trials.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT),
...Access Business Finance LLC, Alnylam Pharmaceuticals Inc, Biopharmaceutical, British Columbia, Comanche Livestock Exchange LLC, designer, Dr Stock Pick, Drug Candidate, Ebay, eMagin Corporation;, Green Energy Live, high resolution imaging products, human disease, Ingram Micro Inc., leader in OLED technology, Lexicon Pharmaceuticals Inc.;, LX4211, Medtronic Inc, Narciso Rodriguez, Narciso Rodriguez eBay Store, OLED technology, OLED;, online marketplace, orally-delivered, small molecule drug candidate, Stocks to Watch, systems integrators, Texas, treatment of Huntington’s disease, type 2 diabetes mellitus, United States, USD, VANCOUVER, World Congress;
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.